Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease.
Zekavat SM, Viana-Huete V, Matesanz N, Jorshery SD, Zuriaga MA, Uddin MM, Trinder M, Paruchuri K, Zorita V, Ferrer-Pérez A, Amorós-Pérez M, Kunderfranco P, Carriero R, Greco CM, Aroca-Crevillen A, Hidalgo A, Damrauer SM, Ballantyne CM, Niroula A, Gibson CJ, Pirruccello J, Griffin G, Ebert BL, Libby P, Fuster V, Zhao H, Ghassemi M, Natarajan P, Bick AG, Fuster JJ, Klarin D. Zekavat SM, et al. Among authors: niroula a. Nat Cardiovasc Res. 2023 Jan 16;2:144-158. doi: 10.1038/s44161-022-00206-6. Nat Cardiovasc Res. 2023. PMID: 36949957 Free PMC article.
S100A6 is a critical regulator of hematopoietic stem cells.
Grahn THM, Niroula A, Végvári Á, Oburoglu L, Pertesi M, Warsi S, Safi F, Miharada N, Garcia SC, Siva K, Liu Y, Rörby E, Nilsson B, Zubarev RA, Karlsson S. Grahn THM, et al. Among authors: niroula a. Leukemia. 2020 Dec;34(12):3323-3337. doi: 10.1038/s41375-020-0901-2. Epub 2020 Jun 19. Leukemia. 2020. PMID: 32555370 Free PMC article.
Correction: S100A6 is a critical regulator of hematopoietic stem cells.
Grahn THM, Niroula A, Végvári Á, Oburoglu L, Pertesi M, Warsi S, Safi F, Miharada N, Capellera-Garcia S, Siva K, Liu Y, Rörby E, Nilsson B, Zubarev RA, Karlsson S. Grahn THM, et al. Among authors: niroula a. Leukemia. 2020 Dec;34(12):3439. doi: 10.1038/s41375-020-0971-1. Leukemia. 2020. PMID: 32665696 Free PMC article.
Germline variants at SOHLH2 influence multiple myeloma risk.
Duran-Lozano L, Thorleifsson G, Lopez de Lapuente Portilla A, Niroula A, Went M, Thodberg M, Pertesi M, Ajore R, Cafaro C, Olason PI, Stefansdottir L, Bragi Walters G, Halldorsson GH, Turesson I, Kaiser MF, Weinhold N, Abildgaard N, Andersen NF, Mellqvist UH, Waage A, Juul-Vangsted A, Thorsteinsdottir U, Hansson M, Houlston R, Rafnar T, Stefansson K, Nilsson B. Duran-Lozano L, et al. Among authors: niroula a. Blood Cancer J. 2021 Apr 19;11(4):76. doi: 10.1038/s41408-021-00468-6. Blood Cancer J. 2021. PMID: 33875642 Free PMC article.
ProTstab - predictor for cellular protein stability.
Yang Y, Ding X, Zhu G, Niroula A, Lv Q, Vihinen M. Yang Y, et al. Among authors: niroula a. BMC Genomics. 2019 Nov 4;20(1):804. doi: 10.1186/s12864-019-6138-7. BMC Genomics. 2019. PMID: 31684883 Free PMC article.
Identification of germline variants in adults with hemophagocytic lymphohistiocytosis.
Miller PG, Niroula A, Ceremsak JJ, Gibson CJ, Taylor MS, Birndt S, Perner F, Arnason J, Sperling AS, Agrawal M, Schram AM, Nikiforow S, Pihan G, Hasserjian RP, Aster JC, La Rosée P, Morgan EA, Berliner N, Ebert BL. Miller PG, et al. Among authors: niroula a. Blood Adv. 2020 Mar 10;4(5):925-929. doi: 10.1182/bloodadvances.2019001272. Blood Adv. 2020. PMID: 32150605 Free PMC article.
102 results